Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
| Revenue (Most Recent Fiscal Year) | $113.69M |
| Net Income (Most Recent Fiscal Year) | $-127.98M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.69 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.59 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -72.61% |
| Net Margin (Trailing 12 Months) | -73.12% |
| Return on Equity (Trailing 12 Months) | -71.37% |
| Return on Assets (Trailing 12 Months) | -30.11% |
| Current Ratio (Most Recent Fiscal Quarter) | 7.09 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.77 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.69 |
| Inventory Turnover (Trailing 12 Months) | 1.38 |
| Book Value per Share (Most Recent Fiscal Quarter) | $7.63 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.98 |
| Earnings per Share (Most Recent Fiscal Year) | $-35.38 |
| Diluted Earnings per Share (Trailing 12 Months) | $-13.05 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 18.15M |
| Free Float | 17.72M |
| Market Capitalization | $82.96M |
| Average Volume (Last 20 Days) | 0.67M |
| Beta (Past 60 Months) | 2.14 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.40% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |